验证数据展示
经过测试的应用
Positive FC detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 3 publications below |
产品信息
65161-1-Ig targets MICA/MICB in WB, FC applications and shows reactivity with Human samples.
经测试应用 | FC Application Description |
文献引用应用 | WB |
经测试反应性 | Human |
文献引用反应性 | human |
免疫原 | Transfected C1R cells expressing MICA 种属同源性预测 |
宿主/亚型 | Mouse / IgG2a, kappa |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | MHC class I polypeptide-related sequence A |
别名 | MICA, MICB |
计算分子量 | 383 aa, 43 kDa |
GenBank蛋白编号 | BC016929 |
基因名称 | MICA |
Gene ID (NCBI) | 100507436 |
RRID | AB_2881478 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Purified by protein-A affinity chromatography |
UNIPROT ID | Q29983 |
储存缓冲液 | PBS with 0.09% sodium azide. |
储存条件 | Store at 2-8°C. Stable for one year after shipment. |
背景介绍
Human MHC class I chain-related genes located within the HLA class I region of chromosome 6 encode MHC class I chain-related A and B (MICA and MICB) (PMID: 11429322). MICA and MICB are stress-inducible surface molecules that are not associated with β2-microglobulin and do not present peptides (PMID: 9497295). They are expressed in intestinal epithelium and many epithelial tumors (PMID: 10359807). MICA and MICB are ligands for NKG2D which is an activating receptor that is expressed on most natural killer (NK) cells, CD8 αβ T cells, and γδ T cells (PMID: 10426993; 11491531). The monoclonal antibody 6D4 recognizes MICA and MICB.
实验方案
Product Specific Protocols | |
---|---|
FC protocol for MICA/MICB antibody 65161-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
J Immunother BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma. | ||
Int Immunopharmacol Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. | ||
Cancers (Basel) circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt Axis |